CSIMarket
 
Sqz Biotechnologies Company  (SQZB)
 
Price: $0.0240 $0.00 0.000%
Day's High: $0.024000000208616257 Week Perf: 0.00
Day's Low: $ 0.02 30 Day Perf: 0.00
Volume (M): 1,000 52 Wk High: $ 0.05
Volume (M$): $ 0 52 Wk Avg: $0.02
Open: $0.02 52 Wk Low: $0.02



 Market Capitalization (Millions $) 1
 Shares Outstanding (Millions) 29
 Employees 43
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -18
 Cash Flow (TTM) (Millions $) -74
 Capital Exp. (TTM) (Millions $) 0

Business Description


Sqz Biotechnologies is a biotechnology company based in Watertown, Massachusetts. The company specializes in developing cell therapies using a proprietary technology called Cell Squeeze. This technology enables the delivery of various molecules, including nucleic acids, proteins, and small molecules, directly into cells using mechanical compression.

Sqz Biotechnologies aims to revolutionize cell therapies by efficiently engineering immune cells for targeted therapeutic purposes. They have developed a diverse pipeline of cell therapies that target various diseases, including cancer, autoimmune disorders, and infectious diseases. The company's approach focuses on improving the effectiveness and specificity of cell therapies, ultimately leading to better patient outcomes.

Sqz Biotechnologies has established partnerships with several pharmaceutical companies and academic institutions to develop innovative cell therapies. They have also received significant investments and funding to support their research and development efforts. Overall, the company is at the cutting edge of cell engineering and is dedicated to advancing the field of cell therapies for the benefit of patients.


   Company Address: 200 Arsenal Yards Blvd Watertown 2472 MA
   Company Phone Number: 758-8672   Stock Exchange / Ticker: SQZB


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
DNA        0.44% 
IMCR   -0.79%    
MRNA        1.04% 
NVAX        5.76% 
PSTX        5.76% 
RGNX        17.94% 
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.06
Price to Sales (Expected) -
Price to Book 0.38
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.15
Working Capital Ratio 1.37
Leverage Ratio (MRQ) 14.84
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -2.44 $
Revenues (TTM) 0.41 $
Cash Flow (TTM) -
Cash 0.35 $
Book Value 0.06 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -411,326
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.